富士製薬工業(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4554/E00975 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/08/28 | 日証協 | 96,500株 | -15.72% | 36,300株 | +79.7% | 153,737株 | -5.59% | 8,000株 | -29.82% |
2020/08/21 | 日証協 | 114,500株 | -7.81% | 20,200株 | +48.53% | 162,837株 | -5.89% | 11,400株 | +67.65% |
2020/08/14 | 日証協 | 124,200株 | +2.05% | 13,600株 | -58.41% | 173,037株 | -0.75% | 6,800株 | -26.88% |
2020/08/07 | 日証協 | 121,700株 | +15.68% | 32,700株 | +37.39% | 174,337株 | +3.32% | 9,300株 | -21.85% |
2020/07/22 | 日証協 | 106,300株 | +11.89% | 16,800株 | -26.96% | 173,037株 | +0.23% | 5,000株 | -50% |
2020/07/17 | 日証協 | 95,000株 | -6.5% | 23,000株 | -37.84% | 172,637株 | -13.44% | 10,000株 | -55.16% |
2020/07/10 | 日証協 | 101,600株 | +13.6% | 37,000株 | +124.24% | 199,437株 | +7.61% | 22,300株 | +106.48% |
2020/07/03 | 日証協 | 89,440株 | -4.79% | 16,500株 | +30.54% | 185,337株 | -3.64% | 10,800株 | +5.88% |
2020/06/26 | 日証協 | 93,940株 | -7.27% | 12,640株 | +208.29% | 192,337株 | -5.41% | 10,200株 | -35.85% |
2020/06/12 | 日証協 | 102,900株 | +13.45% | 40,596株 | -45.43% | 201,837株 | +0.1% | 2,900株 | -87% |
2020/06/05 | 日証協 | 90,700株 | -5.62% | 74,396株 | +5622.77% | 201,626株 | -2.38% | 22,311株 | +178.16% |
2020/05/29 | 日証協 | 96,100株 | -8.56% | 1,300株 | -96.72% | 206,547株 | -6.21% | 8,021株 | -58.7% |
2020/05/22 | 日証協 | 105,100株 | -6.49% | 39,600株 | -45.68% | 220,226株 | +1.61% | 19,421株 | -45.85% |
2020/05/15 | 日証協 | 112,400株 | +15.92% | 72,898株 | +73.25% | 216,726株 | +11.07% | 35,863株 | +79.31% |
2020/05/08 | 日証協 | 96,962株 | +14.39% | 42,076株 | -56.63% | 195,126株 | +9.73% | 20,001株 | -68.85% |
2020/05/01 | 日証協 | 84,762株 | +0.59% | 97,008株 | +48.43% | 177,826株 | +2.01% | 64,200株 | +9.18% |
2020/04/24 | 日証協 | 84,263株 | +15.01% | 65,354株 | +36.94% | 174,326株 | +7% | 58,801株 | -21.49% |
2020/04/17 | 日証協 | 73,263株 | -9.06% | 47,723株 | +106.6% | 162,926株 | -2.57% | 74,900株 | +359.48% |
2020/04/10 | 日証協 | 80,562株 | +19.77% | 23,099株 | -38.67% | 167,226株 | -1.68% | 16,301株 | -69.75% |
※株式分割は考慮していませんのでご注意ください。
Page Top